Iterum Therapeutics plc (ITRMF) Other Non-Current Liabilities (2017 - 2024)

Iterum Therapeutics has reported Other Non-Current Liabilities for 8 years, with the latest figure at $16000.0 in Q2 2024.

• On a quarterly basis, Other Non-Current Liabilities fell 98.6% year-over-year to $16000.0 in Q2 2024; TTM through Jun 2024 was $16000.0, a 98.6% decrease from a year earlier, with the FY2023 full-year figure at $188000.0, down 85.58% from the prior year.
• Other Non-Current Liabilities was $16000.0 for Q2 2024 at Iterum Therapeutics, down from $92000.0 in the prior quarter.
• The five-year high for Other Non-Current Liabilities was $7.2 million in Q3 2020, with the low at $16000.0 in Q2 2024.
• Average Other Non-Current Liabilities over 5 years is $3.0 million, with a median of $2.5 million recorded in 2022.
• The sharpest annual moves came in 2020 and 2024: Other Non-Current Liabilities fell 2.73% in 2020, then plunged 98.6% in 2024.
• Over 5 years, Other Non-Current Liabilities stood at $5.8 million in 2020, then plunged by 40.78% to $3.4 million in 2021, then sank by 62.05% to $1.3 million in 2022, then tumbled by 85.58% to $188000.0 in 2023, then tumbled by 91.49% to $16000.0 in 2024.
• The last three Other Non-Current Liabilities figures came in at $16000.0 (Q2 2024), $92000.0 (Q1 2024), and $188000.0 (Q4 2023), per Business Quant data.